DE:6Q40 / MiNK Therapeutics, Inc. - Net Long/Short Value

MiNK Therapeutics, Inc.
DE ˙ DB ˙ US6036931029
DE:6Q40 / MiNK Therapeutics, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Longbow Finance SA
Vanguard Capital Management Llc
Morgan Stanley
Vanguard Group Inc
Jones Financial Companies Lllp
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Sa
Steward Partners Investment Advisory, Llc
Tower Research Capital LLC (TRC)
BlackRock, Inc.
Caitong International Asset Management Co., Ltd
Covestor Ltd
Pinnacle Wealth Planning Services, Inc.
Geode Capital Management, Llc
Game Plan Financial Advisors, LLC
Vanguard Fiduciary Trust Co
Northwestern Mutual Wealth Management Co
Hartland & Co., LLC
Advisor Group Holdings, Inc.
UBS Group AG
Annis Gardner Whiting Capital Advisors, LLC
Citigroup Inc
Key FInancial Inc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:INKT 12,76 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista